These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Concentration of LDLR, degree of hepatic fibrosis and hepatic steatosis in patients with chronic hepatitis B infection treated with tenofovir disoproxil fumarate. Pokora-Rodak A; Krzowska-Firych J; Tomasiewicz K Ann Agric Environ Med; 2021 Sep; 28(3):458-462. PubMed ID: 34558270 [TBL] [Abstract][Full Text] [Related]
6. Editorial: effect of hepatic steatosis on liver stiffness in patients with chronic hepatitis B-authors' reply. Shen F; Fan JG Aliment Pharmacol Ther; 2019 Aug; 50(3):334-335. PubMed ID: 31313361 [No Abstract] [Full Text] [Related]
7. [Hepatic steatosis in chronic hepatitis B: prevalence, risk factors, and impact on fibrosis and therapeutic response]. Ben Slama Trabelsi A; Ksiaa M; Souguir A; Issaoui D; Sriha B; Ajmi S Tunis Med; 2013 Jul; 91(7):431-4. PubMed ID: 24008872 [TBL] [Abstract][Full Text] [Related]
8. Diverse effects of hepatic steatosis on fibrosis progression and functional cure in virologically quiescent chronic hepatitis B. Mak LY; Hui RW; Fung J; Liu F; Wong DK; Cheung KS; Yuen MF; Seto WK J Hepatol; 2020 Oct; 73(4):800-806. PubMed ID: 32504663 [TBL] [Abstract][Full Text] [Related]
9. Hepatic steatosis in chronic hepatitis B and C: predictors, distribution and effect on fibrosis. Gordon A; McLean CA; Pedersen JS; Bailey MJ; Roberts SK J Hepatol; 2005 Jul; 43(1):38-44. PubMed ID: 15876468 [TBL] [Abstract][Full Text] [Related]
10. Hepatic steatosis and fibrosis in young men with treatment-naïve chronic hepatitis B. Yun JW; Cho YK; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI; Son BH; Shin JH Liver Int; 2009 Jul; 29(6):878-83. PubMed ID: 19192167 [TBL] [Abstract][Full Text] [Related]
11. Letter: moderate-to-severe hepatic steatosis leads to overestimation of liver stiffness measurement in chronic hepatitis B patients without significant fibrosis. Dong JJ; Cai YJ Aliment Pharmacol Ther; 2019 Sep; 50(5):616. PubMed ID: 31414535 [No Abstract] [Full Text] [Related]
13. Prevalence of liver steatosis in patients with chronic hepatitis B: a study of associated factors and of relationship with fibrosis. Thomopoulos KC; Arvaniti V; Tsamantas AC; Dimitropoulou D; Gogos CA; Siagris D; Theocharis GJ; Labropoulou-Karatza C Eur J Gastroenterol Hepatol; 2006 Mar; 18(3):233-7. PubMed ID: 16462535 [TBL] [Abstract][Full Text] [Related]
14. Fatty liver is associated with advanced fibrosis but does not predict adverse outcomes in patients with chronic hepatitis B. Wong SW; Chan WK; Mohamed R J Viral Hepat; 2020 Dec; 27(12):1297-1305. PubMed ID: 32668489 [TBL] [Abstract][Full Text] [Related]
15. The prevalence of steatohepatitis in chronic hepatitis B patients and its impact on disease severity and treatment response. Charatcharoenwitthaya P; Pongpaibul A; Kaosombatwattana U; Bhanthumkomol P; Bandidniyamanon W; Pausawasdi N; Tanwandee T Liver Int; 2017 Apr; 37(4):542-551. PubMed ID: 27740738 [TBL] [Abstract][Full Text] [Related]
16. Association Between Hepatic Steatosis, Measured by Controlled Attenuation Parameter, and Fibrosis Burden in Chronic Hepatitis B. Seto WK; Hui RWH; Mak LY; Fung J; Cheung KS; Liu KSH; Wong DK; Lai CL; Yuen MF Clin Gastroenterol Hepatol; 2018 Apr; 16(4):575-583.e2. PubMed ID: 28970146 [TBL] [Abstract][Full Text] [Related]
17. Letter to the Editor: Hepatic steatosis and glycemic burden in chronic hepatitis B. Huang SC; Kao JH Hepatology; 2023 Jul; 78(1):E11. PubMed ID: 36929778 [No Abstract] [Full Text] [Related]
18. Association of adipokines with hepatic steatosis and fibrosis in chronic hepatitis B patients on long-term nucleoside analogue. Mak LY; Lee CH; Cheung KS; Wong DK; Liu F; Hui RW; Fung J; Xu A; Lam KS; Yuen MF; Seto WK Liver Int; 2019 Jul; 39(7):1217-1225. PubMed ID: 30912255 [TBL] [Abstract][Full Text] [Related]
19. Letter: tenofovir versus entecavir for hepatocellular carcinoma prevention in chronic hepatitis B-related compensated cirrhosis-authors' reply. Chiu SY; Chang KC; Hu TH; Chien RN Aliment Pharmacol Ther; 2021 May; 53(9):1042-1043. PubMed ID: 33831240 [No Abstract] [Full Text] [Related]
20. Predictors of hepatic steatosis in HBeAg-negative chronic hepatitis B patients and their diagnostic values in hepatic fibrosis. Zheng RD; Xu CR; Jiang L; Dou AX; Zhou K; Lu LG Int J Med Sci; 2010 Aug; 7(5):272-7. PubMed ID: 20714438 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]